Relationship between tumour necrosis factor-related apoptosis inducing ligand (TRAIL) and vascular endothelial growth factor in human multiple myeloma patients-Reference-Cited by-同舟云学术

Relationship between tumour necrosis factor-related apoptosis inducing ligand (TRAIL) and vascular endothelial growth factor in human multiple myeloma patients

Published:2014-11-05 Issue:4 Volume:33 Page:199-205
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Bolkun Lukasz¹,Lemancewicz Dorota¹²,Piszcz Jaroslaw¹,Moniuszko Marcin³⁴,Bolkun-Skornicka Urszula⁵,Szkiladz Malgorzata¹,Jablonska Ewa⁶,Kloczko Janusz¹,Dzieciol Janusz²

Affiliation:

1. Department of Haematology; Medical University of Bialystok; Poland

2. Department of Human Anatomy; Medical University of Bialystok; Poland

3. Department of Regenerative Medicine and Immune Regulation; Medical University of Bialystok; Poland

4. Department of Allergology and Internal Medicine; Medical University of Bialystok; Poland

5. Department of Pharmaceutical Technology; Medical University of Bialystok; Poland

6. Department of Immunology; Medical University of Bialystok; Poland

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference38 articles.

1. Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients;Corso;Haematologica,2001

2. Multiple myeloma: increasing evidence for a multistep transformation process;Hallek;Blood,1998

3. Angiogenesis;Folkman;J Biol Chem,1992

4. Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis;Hanahan;Cell,1996

5. Angiogenesis in cancer and other diseases;Carmeliet;Nature,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of Apoptosis Pathways in the Biology and Treatment of Multiple Myeloma;Oncology & Haematology;2021

2. Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy;Ocular Immunology and Inflammation;2017-09-15